Company Search:
Advanced Search
Sponsored Links
Chembio Diagnostics, Inc. Company Snapshot
Chembio Diagnostics, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Chembio Diagnostics with three other companies in this sector in UNITED STATES : Reliv' International, Inc. (2019 sales of $35.06 million ), Dynavax Technologies Corporation ($35.22 million of which 100% was Biopharmaceutical Product), and OptiNose Inc ($34.63 million of which 100% was Pharmaceutical).

Sales Analysis. Chembio Diagnostics reported sales of $34.46 million for the year ending December of 2019. This represents an increase of 3.2% versus 2018, when the company's sales were $33.41 million. This was the third consecutive year of growth at Chembio Diagnostics.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Chembio Diagnostics, Inc.
  Stock Performance Chart for Chembio Diagnostics, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 5.53
(Figures in U.S. Dollars)
1 Week 9.1%   13 Weeks 32.3%  
4 Weeks -56.5%   52 Weeks -8.1%  
Chembio Diagnostics, Inc. Key Data:
  Ticker: CEMI Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 34,464,032
(Year Ending Jan 2020).
Employees: 295
  Currency: U.S. Dollars Market Cap: 95,645,492
  Fiscal Yr Ends: December Shares Outstanding: 17,295,749
  Share Type: Common Closely Held Shares: 3,352,383
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.